While tau neuropathology is usually much better correlated to clinical symptoms and to the progression of disease than Aβ neuropathology3, there is strong evidence linking Aβ to AD and suggesting a role as a trigger of disease onset. The gene discussed is MAPT; the disease is Alzheimer disease.